Alatrofloxacin Mesylate Patent Expiration
Alatrofloxacin Mesylate is Used for treating bacterial infections. It was first introduced by Pfizer Chemicals Div Pfizer Inc
Alatrofloxacin Mesylate Patents
Given below is the list of patents protecting Alatrofloxacin Mesylate, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Trovan Preservative Free | US5763454 | Crystal form of anhydrous 7-( 1α,5α,6α!-6-amino-3-azabicyclo 3.1.0!hex-3-yl)-6-fluoro-1-(2,4-difluorophenyl)-1,4-dihydro-4-oxo-1,8 naphthyridine-3-carboxylic acid, methanessulfonic acid salt |
Jun 15, 2015
(Expired) | Pfizer |
| Trovan Preservative Free | US6080756 | Polymorphs of the prodrug 6-N-(L-ALA-L-ALA)-trovafloxacin |
Jul 05, 2016
(Expired) | Pfizer |
| Trovan Preservative Free | US6194429 | Alatrofloxacin parenteral compositions |
Jul 23, 2018
(Expired) | Pfizer |